TS
Todd Sone
OtherActiveGeneral Partner at aMoon Fund
Israel, IsraelFounded 2017
26
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Todd Sone.
Investment Thesis & Strategy
Todd Sone, as a General Partner at aMoon Fund, invests in various stages of biotech, consumer health, healthcare, health & hospital services, and health IT companies, seeking innovative solutions and technologies within the healthcare sector.
Investment Activity
Deals per year over the last 3 years
3
20163
20176
2018Portfolio Companies
Selected investments from their portfolio of 26 companies
N
NanoGhosts
Biotech · Seed, 2018
C
CuResponse
Biotech · Seed, 2018
N
Nectin Therapeutics
Biotech · Series A, 2018
V
Vocalis Health
Healthcare · Series A, 2018
M
Mammoth Biosciences
Biotech · Series B, 2018
S
Seer
Biotech · Series C+, 2018
N
Nobio
Healthcare · Seed, 2017
M
Mobilion Systems
Biotech · Series A, 2017
A
Ayala Pharmaceuticals
Biotech · Series B, 2017
I
Igentify
Biotech · Seed, 2016
S
Scipher Medicine
Biotech · Series C+, 2016
I
Ibex Medical Analytics
AI/ML · Series B, 2016
Frequently Asked Questions
Todd Sone focuses on Seed stage investments.